Pfizer files for US authorization of coronavırus pill
Pfizer announced on Tuesday that it has completed submission for emergency use authorization of its experimental antiviral COVID-19 pill with the U.S. Food and Drug Administration.
Pfizer announced on Tuesday that it has completed submission for emergency use authorization of its experimental antiviral COVID-19 pill with the U.S. Food and Drug Administration.